Reducing Falls through targeted Sarcopenia Management: Findings from an MDT Sarcopenia Clinic from Qatar

Introduction:

Sarcopenia is recognized as a correlate of ageing and is associated with increased likelihood of adverse outcomes such as decreased mobility, impaired standing balance, functional decline, Falls and Frailty.  

To address age related Sarcopenia, an MDT clinic was established in Rumailah hospital which brought expertise from Geriatricians, Physiotherapists and Clinical Dietitians.

Methods:

The Sarcopenia clinic enrolled older adults (>60 years) in the and assessments included SARC-F, handgrip dynamometry, frailty measurements, SPPB, TUG, and BIA. Interventions comprised CGA, progressive resistance and balance training, and individualized nutrition (1.25–1.5 g/kg/day protein, vitamin D, Omega 3 FAs, and supplements where indicated). Follow-ups at 6-, 14-, and 24-weeks reassessed outcomes. MDT reviews ensured personalized adjustments. Data collection followed standardized protocols, and compliance was reinforced via exercise diaries and caregivers.

Results:

Early data demonstrate:

• Reversal of frailty indicators
• Improved orthostatic hypotension symptoms
• Reduction in Falls incidence
• Increased handgrip strength and SPPB scores
• Enhanced gait speed and TUG performance
• Gains in muscle mass (via BIA)
• Improved nutritional screening scores

Several cases transitioned from sarcopenia to non-sarcopenic status within six months. Patients reported reduced fatigue, fewer falls, and improved independence in daily activities.

Conclusion

The Sarcopenia MDT Clinic demonstrates that integrated medical, physiotherapy, and nutritional interventions can reverse sarcopenia, reduce falls, and improve QOL in older adults. By combining standardized assessments with progressive therapy and dietary optimization, the clinic addresses a critical gap in geriatric services. This innovative model strengthens both clinical outcomes and research capacity in Qatar, offering a replicable framework for healthy ageing strategies worldwide. Sustained MDT collaboration essential for advancing sarcopenia management and preventing frailty-related complications.